Cargando…
Differentiation therapy for myeloid malignancies: beyond cytotoxicity
Blocked cellular differentiation is a central pathologic feature of the myeloid malignancies, myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML). Treatment regimens promoting differentiation have resulted in incredible cure rates in certain AML subtypes, such as acute promyelocytic leuk...
Autores principales: | Stubbins, Ryan J., Karsan, Aly |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8643352/ https://www.ncbi.nlm.nih.gov/pubmed/34864823 http://dx.doi.org/10.1038/s41408-021-00584-3 |
Ejemplares similares
-
Management of Acute Myeloid Leukemia: A Review for General Practitioners in Oncology
por: Stubbins, Ryan J., et al.
Publicado: (2022) -
A clinical transcriptome approach to patient stratification and therapy selection in acute myeloid leukemia
por: Docking, T. Roderick, et al.
Publicado: (2021) -
Therapy-Related Myeloid Malignancies in Myeloma
por: Papanikolaou, X., et al.
Publicado: (2011) -
Telomerase-targeted therapies in myeloid malignancies
por: Waksal, Julian A., et al.
Publicado: (2023) -
Targeting Chromatin Complexes in Myeloid Malignancies and Beyond: From Basic Mechanisms to Clinical Innovation
por: Perner, Florian, et al.
Publicado: (2020)